MedTrace Logo

A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

NCT06264453 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2025-03-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of KH001 in patients with dentin hypersensitivity.

Conditions

  • Dentin Hypersensitivity

Interventions

DRUG

KH001

topical applications of KH001

DRUG

Placebo

topical applications of Water for Injection

Sponsors & Collaborators

  • HysensBio Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Kyoung-Kyu Choi, D.D.S · Kyung Hee University Dentistry Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-19
Primary Completion
2024-09-25
Completion
2024-09-25

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06264453 on ClinicalTrials.gov